APA (7th ed.) Citation

Alzaaqi, S., Naka, N., Hamada, K., Hosen, N., Kanegae, M., Outani, H., . . . Oji, Y. (2022). WT1 epitope-specific IgG and IgM antibodies for immune-monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine. Oncology Letters, 23(2), N.PAG. https://doi.org/10.3892/ol.2022.13184

Chicago Style (17th ed.) Citation

Alzaaqi, Shouq, et al. "WT1 Epitope-specific IgG and IgM Antibodies for Immune-monitoring in Patients with Advanced Sarcoma Treated with a WT1 Peptide Cancer Vaccine." Oncology Letters 23, no. 2 (2022): N.PAG. https://doi.org/10.3892/ol.2022.13184.

MLA (9th ed.) Citation

Alzaaqi, Shouq, et al. "WT1 Epitope-specific IgG and IgM Antibodies for Immune-monitoring in Patients with Advanced Sarcoma Treated with a WT1 Peptide Cancer Vaccine." Oncology Letters, vol. 23, no. 2, 2022, p. N.PAG, https://doi.org/10.3892/ol.2022.13184.